Core set of conceptual criteria to be used for defining response in ET and PV
Response category/essential thrombocythemia . | Response category/polycythemia vera . |
---|---|
Clinicohematologic | |
Reduction/normalization of platelet count | Reduction of phlebotomy requirement to maintain the hematocrit at the target level |
Resolution of disease-related symptoms* | Reduction/normalization of platelet count |
Reduction/normalization of splenomegaly on imaging | Reduction/normalization of white blood cell count |
Reduction/normalization of white blood cell count | Reduction/normalization of splenomegaly on imaging |
Resolution of disease-related symptoms* | |
Molecular | |
Reduction of any specific molecular abnormalities | Reduction of any specific molecular abnormalities |
Histologic | |
Bone marrow histologic remission defined as the disappearance of megakaryocyte hyperplasia | Bone marrow histologic remission defined as the presence of age-adjusted normocellularity and no reticulin fibrosis |
Response category/essential thrombocythemia . | Response category/polycythemia vera . |
---|---|
Clinicohematologic | |
Reduction/normalization of platelet count | Reduction of phlebotomy requirement to maintain the hematocrit at the target level |
Resolution of disease-related symptoms* | Reduction/normalization of platelet count |
Reduction/normalization of splenomegaly on imaging | Reduction/normalization of white blood cell count |
Reduction/normalization of white blood cell count | Reduction/normalization of splenomegaly on imaging |
Resolution of disease-related symptoms* | |
Molecular | |
Reduction of any specific molecular abnormalities | Reduction of any specific molecular abnormalities |
Histologic | |
Bone marrow histologic remission defined as the disappearance of megakaryocyte hyperplasia | Bone marrow histologic remission defined as the presence of age-adjusted normocellularity and no reticulin fibrosis |
Disease-related symptoms: microvascular disturbances, pruritus, headache.